# Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer

> **NCT01341886** · NA · COMPLETED · sponsor: **Mashhad University of Medical Sciences** · enrollment: 51 (actual)

## Conditions studied

- Malignant Neoplasm of Thyroid Stage I
- Malignant Neoplasm of Thyroid Stage II

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01341886
- **Lead sponsor:** Mashhad University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2011-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341886, "Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01341886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*